Transforming Allogeneic Cell Therapy for Blood, Genetic and Immune Diseases
Orca Bio is dedicated to developing high-precision allogeneic cell therapies designed to safely replace patients’ diseased blood and immune system with a healthy one.
Transforming Allogeneic Cell Therapy for Blood, Genetic and Immune Diseases
Orca Bio is dedicated to developing high-precision allogeneic cell therapies designed to safely replace patients’ diseased blood and immune system with a healthy one.
Orca-T clinical data presented at 2021 TCT. View press release here
